TALPHERA, INC. cotiza a 1.08 USD y tiene una capitalización bursátil de $56M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal c…
| Periodo | 2026-11 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.05 | $-0.06 | $-0.11 |
| Estimado | $-0.05 | $-0.08 | $-0.07 | $-0.11 |
| Sorpresa | — | +37.5% | +14.3% | +0.0% |
| Métrica | TLPH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -48157.1% | -38.6% | -48118.5% |
| Net Margin | -51035.7% | -33.6% | -51002.2% |
| FCF Margin | — | -13.9% | — |
| ROE | -83.9% | -40.4% | -43.5% |
| ROA | -48.1% | -32.0% | -16.1% |
| Current Ratio | 5.49 | 2.84 | +2.65 |
| Debt / Equity | — | 0.28 | — |